欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (1): 93-100.doi: 10.12092/j.issn.1009-2501.2023.01.012

• 综述与讲座 • 上一篇    下一篇

m7G甲基转移酶METTL1在肿瘤中的作用

洪子强1,3,苟文曦2,崔百强1,3,白向豆1,3,金大成3,苟云久3   

  1. 1甘肃中医药大学 第一临床医学院,兰州  730000,甘肃;
    2南方医科大学,广州  510515,广东;3甘肃省人民医院 胸外科,兰州  730000,甘肃

  • 收稿日期:2022-09-20 修回日期:2022-11-27 出版日期:2023-01-26 发布日期:2023-02-14
  • 通讯作者: 苟云久,男,医学博士,教授,主任医师,研究方向:胸部肿瘤的基础研究及胸部肿瘤的微创手术治疗。 E-mail: gouyunjiu@163.com
  • 作者简介:洪子强,男,硕士研究生,研究方向:胸部肿瘤的基础研究及胸部肿瘤的微创治疗。 E-mail: 1032956679@qq.com
  • 基金资助:
    甘肃省自然科学基金(20JR10RA388);甘肃省卫生健康行业科研计划项目(GSWSKY2020-50)

Role of the m7G methyltransferase METTL1 in tumours

HONG Ziqiang1,3, GOU Wenxi2, CUI Baiqiang1,3, BAI Xiangdou1,3, JIN Dacheng3, GOU Yunjiu3   

  1. 1The First Clinical Department of Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu, China; 2Southern Medical University, Guangzhou 510515, Guangdong, China; 3Department of Thoracic Surgery, Gansu Provincial Hospital, Lanzhou 730000, Gansu, China
  • Received:2022-09-20 Revised:2022-11-27 Online:2023-01-26 Published:2023-02-14

摘要: N7甲基鸟嘌呤核苷酸(N7-methylguanosine, m7G)是一种常见的RNA转录后修饰,在RNA加工、代谢和功能中起着重要作用。其主要由甲基转移酶1(methyltransferase 1, METTL1)和WD重复结构域4(WD repeat domain 4, WDR4)复合物调控。多项研究表明,METTL1/WDR4复合物促进或抑制许多肿瘤的进程,包括头颈部肿瘤、肺癌、肝癌、结肠癌、膀胱癌和食管鳞癌等,这依赖于tRNA或miRNA的m7G甲基化修饰。因此,METTL1和m7G修饰可以用作生物标志物或潜在的干预靶点,为肿瘤的早期诊断和治疗提供新的方向。本文将主要讨论METTL1通过m7G在肿瘤发生中的作用机制和相关的研究进展。

关键词: 表观遗传修饰, RNA甲基化, m7G, METTL1, 肿瘤

Abstract:

N7-methylguanosine (m7G) is a common post-transcriptional modification of RNA that plays an important role in RNA processing, metabolism and function and is mainly regulated by the methyltransferase 1 (METTL1) and WD repeat domain 4 (WDR4) complexes. Several studies have shown that the METTL1/WDR4 complex promotes or inhibits the progression of many tumours, including head and neck tumours, lung, liver, colon, bladder and esophageal squamous cancers, which are dependent on m7G methylation modification of tRNA or miRNA. Therefore, METTL1 and m7G modification can be used as biomarkers or potential intervention targets, providing a new direction for early diagnosis and treatment of tumors. This article will mainly discuss the mechanism and corresponding research progress of METTL1 in tumorigenesis through m7G.

Key words: epigenetic modification, RNA methylation, m7G, METTL1, tumor

中图分类号: